Melissa L. Garcia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Melissa L. Garcia has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Ann M. Laszczyk
University of Alabama at Birmingham
1 shared publication- Dailey Nettles
Department of Neurosurgery, The University of Colorado Anschutz Medical Campus
1 shared publication - Gwendalyn D. King
Department of Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA
1 shared publication - Jing Wang
University of Alabama at Birmingham
1 shared publication L. Darryl Quarles
University of Tennessee Medical Health Science Center
1 shared publication- Stephanie N. Fox
Killion Center for Neurodegeneration and Experimental Therapeutics, Frances Gorrie Alzheimer’s Disease Center, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35233, USA
1 shared publication
Latest Publications
- Open Access
- 7 March 2019
- Published by Society for Neuroscience in eneuro
- Vol. 6 (2)
FGF-23 Deficiency Impairs Hippocampal-Dependent Cognitive Function
Fibroblast growth factor receptor (FGFR) and α-Klotho transduce FGF-23 signaling in renal tubules to maintain systemic phosphate/vitamin D homeostasis. Mice deficient for either the ligand, FGF-23, or the co-receptor, Klotho, are phenocopies with both showing rapid and premature development of multiple aging-like abnormalities. Such similarity in phenotype, suggests that FGF-23 and Klotho have co-dependent systemic functions. Recent reports revealed inverse central nervous system (CNS) effects of Klotho deficiency or Klotho overexpression on hippocampal synaptic, neurogenic, and cognitive functions. However, it is unknown whether FGF-23 deficiency effects function of the hippocampus. We report that, similar to Klotho-deficient mice, FGF-23-deficient mice develop dose-dependent, hippocampal-dependent cognitive impairment. However, FGF-23-deficient brains had no gross structural or developmental defects, no change in hippocampal synaptic plasticity, and only minor impairment to postnatal hippocampal neurogenesis. Together, these data provide evidence that FGF-23 deficiency impairs hippocampal-dependent cognition but otherwise results in a brain phenotype that is distinct from the KL-deficient mouse.
- 7 March 2019
- Published by Society for Neuroscience in eneuro
- Vol. 6 (2)
Open AccessFGF-23 Deficiency Impairs Hippocampal-Dependent Cognitive Function
Fibroblast growth factor receptor (FGFR) and α-Klotho transduce FGF-23 signaling in renal tubules to maintain systemic phosphate/vitamin D homeostasis. Mice deficient for either the ligand, FGF-23, or the co-receptor, Klotho, are phenocopies with both showing rapid and premature development of multiple aging-like abnormalities. Such similarity in phenotype, suggests that FGF-23 and Klotho have co-dependent systemic functions. Recent reports revealed inverse central nervous system (CNS) effects of Klotho deficiency or Klotho overexpression on hippocampal synaptic, neurogenic, and cognitive functions. However, it is unknown whether FGF-23 deficiency effects function of the hippocampus. We report that, similar to Klotho-deficient mice, FGF-23-deficient mice develop dose-dependent, hippocampal-dependent cognitive impairment. However, FGF-23-deficient brains had no gross structural or developmental defects, no change in hippocampal synaptic plasticity, and only minor impairment to postnatal hippocampal neurogenesis. Together, these data provide evidence that FGF-23 deficiency impairs hippocampal-dependent cognition but otherwise results in a brain phenotype that is distinct from the KL-deficient mouse.